Home › Calculator › RGEN Dividend Calculator 2026
RGEN Dividend DRIP Calculator 2026
1.21% YieldHealthcareRepligen Corporation · NASDAQ
Price: $165.57 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RGEN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RGEN snowball 📈
$10,000 in RGEN → $5.71M in 10 years · $10.20/month
About Repligen Corporation (RGEN) — Dividend Analysis 2026
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography columns, instrumental in purifying biologics, alongside smaller-scale OPUS columns designed for high-throughput process development screening, viral clearance validation studies, and the scaling-down of chromatography processes. Additionally, the company supplies ELISA test kits and chromatography resins marketed under the CaptivA brand. Repligen also boasts an extensive suite of filtration products. This includes XCell Alternating Tangential Flow systems, which are filtration devices utilized in upstream perfusion and cell culture processing. For downstream applications like biologic drug concentration and formulation, they provide TangenX flat sheet cassettes. Other filtration offerings encompass KrosFlo tangential flow filtration and tangential flow depth filtration systems, Spectra/Por laboratory and process dialysis products, SpectraFlo dynamic dialysis systems, and ProConnex single-use hollow fibers. Furthermore, Repligen addresses process analytics with its slope spectroscopy systems, branded as SoloVPE, FlowVPE, and FlowVPX. Their clientele is broad, consisting of life sciences organizations, biopharmaceutical and diagnostics companies, laboratory researchers, and contract manufacturing organizations. Repligen also collaborates with partners, such as Navigo Proteins GmbH, on the development of various affinity ligands. The corporation was founded in 1981 and maintains its corporate headquarters in Waltham, Massachusetts.
Compare RGEN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RGEN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RGEN position with:
🌍 RGEN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RGEN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.21% | -1.59% | $121 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.03% | -1.77% | $103 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.97% | -1.83% | $97 / yr |
| 🇬🇧 UK ISA | 0% | 1.21% | -1.59% | $121 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.10% | -1.70% | $110 / yr |
| 🇨🇦 TFSA | 0% | 1.21% | -1.59% | $121 / yr |
| 🇨🇦 CA Taxable | 25% | 0.91% | -1.89% | $91 / yr |
| 🇦🇺 Super (pension) | 15% | 1.03% | -1.77% | $103 / yr |
| 🇦🇺 AU Taxable | 30% | 0.85% | -1.95% | $85 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.89% | -1.91% | $89 / yr |
| 🇫🇷 FR Taxable | 30% | 0.85% | -1.95% | $85 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RGEN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RGEN Dividend Payment Schedule
RGEN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 RGEN vs Healthcare Benchmarks
How RGEN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RGEN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RGEN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-09-03 | 2,842 | $169.61 | $482.0K | ||
| Sale | 2026-09-04 | 3,035 | $165.90 | $503.5K | ||
| A-Award | 2026-03-05 | 2,466 | — | — | ||
| F-InKind | 2026-09-01 | 277 | $170.02 | $47.1K | ||
| M-Exempt | 2026-08-20 | 5,426 | $141.79 | $769.4K | ||
| Sale | 2026-08-20 | 5,426 | $180.00 | $976.7K | ||
| M-Exempt | 2026-08-20 | 5,426 | $141.79 | $769.4K | ||
| Sale | 2026-07-16 | 530 | $150.00 | $79.5K | ||
| Sale | 2026-06-25 | 733 | $145.00 | $106.3K | ||
| A-Award | 2026-05-14 | 995 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RGEN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Repligen Corporation (RGEN) is currently trading at $165.57, 46% below its 52-week high. The current dividend yield is 1.21% based on an annual payout of $2.00 per share.
RGEN (Repligen Corporation) — 1.21% Dividend Yield Analysis
Repligen Corporation (RGEN) is a healthcare stock currently trading at $165.57 with a dividend yield of 1.21%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.